InsiderTrades

Form 4 for PRVA Privia Health Group, Inc.

Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001759655-26-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-02 2026-02-26+ PRVA Mountcastle David EVP, CFO M - OptEx $2.00 +13.1K 180.6K +8% +$26.1K
DM 2026-03-02 2026-02-26+ PRVA Mountcastle David EVP, CFO S - Sale+OE $25.03 -13.1K 172.9K -7% -$326.8K
DM 2026-03-02 2026-02-26+ PRVA Mountcastle David EVP, CFO M - OptEx $0.00 -13.1K 12.5K -51% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2026-02-26 M A 5,361 $2.00 178,270 D — —
2 Common Common Stock, par value $0.01 per share 2026-02-26 S D 5,361 $25.00 172,909 D — — (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3 Common Common Stock, par value $0.01 per share 2026-02-27 M A 7,697 $2.00 180,606 D — —
4 Common Common Stock, par value $0.01 per share 2026-02-27 S D 7,697 $25.05 172,909 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
5 Derivative Stock Option (Right to Purchase) 2026-02-26 M D 1,668 $0.00 3,833 D $2.00 · — to 2029-12-03 1,668 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
6 Derivative Stock Option (Right to Purchase) 2026-02-26 M D 1,100 $0.00 11,352 D $2.00 · — to 2029-03-20 1,100 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
7 Derivative Stock Option (Right to Purchase) 2026-02-26 M D 1,893 $0.00 15,927 D $2.00 · — to 2028-08-27 1,893 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
8 Derivative Stock Option (Right to Purchase) 2026-02-26 M D 700 $0.00 2,166 D $2.00 · — to 2030-09-07 700 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
9 Derivative Stock Option (Right to Purchase) 2026-02-27 M D 998 $0.00 2,835 D $2.00 · — to 2029-12-03 998 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
10 Derivative Stock Option (Right to Purchase) 2026-02-27 M D 2,699 $0.00 8,653 D $2.00 · — to 2029-03-20 2,699 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
11 Derivative Stock Option (Right to Purchase) 2026-02-27 M D 572 $0.00 1,594 D $2.00 · — to 2030-09-07 572 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.
12 Derivative Stock Option (Right to Purchase) 2026-02-27 M D 3,428 $0.00 12,499 D $2.00 · — to 2028-08-27 3,428 Common Stock, par value $0.01 per share (F4) All of the stock options are fully vested and exercisable.